Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Looking for partners to promote new, patented & registered oral hygiene, skin injury and Gynaecological products.

Looking for partners to distribute highly innovative and effective oral care, skin care and Gynaecological pharmaceuticals

Mechanism of action

A natural, antibacterial, antifungal, healing agent with long lasting activity. Different formulations from this discovery allowed us to complete European registration of 3 new drugs (medical devices)

Full description

Mucous and skin injuries such as mouth ulcers, skin wounds, vaginal dryness and vaginal infections are very common (1/6 world population/year is concerned) but currently there are no ideal treatment. This is obvious as such treatments require dual but contradictory activities of inhibiting the growth of microbial cells on one hand and stimulating the growth of human cells on the other hand. It is also practically impossible to associate two different molecules in the same drug.

An ideal treatment must have anti-bacterial, anti-fungal,and wound cleaning properties. It should not affect natural flora, should keep the wound or the mocosal surface humid, should not be toxic or irritant, should stimulate healing process, should not cause resistance, should have analgesic properties, should have a good taste and should be of natural origin if possible. VITROBIO found and patented in 1997 a natural substance having these properties.

This discovery allowed us to conceive and register in APRIL 2007 three new drugs as medical devices in Europe as the 1st specific treatment for oral aphthous stomatitis, vaginal dryness/infection/injuries/pH equilibrium and skin injuries.

Being a new generation of efficient, natural, safe & broad spectrum products with a unique mode of action, these products have a 20 years + life span.

Each product represent a market potential of 25 000 units per million population.

Key words

Pharmaceutical, Medical device, dermatological, genito urinary, oral health, registered product.

Development status

Registered

Type of business relationship sought

We are looking for 1 exclusive distributor in each country except for France, Belgium, Portugal, Iran, Greece, Algeria, & Tunisia where these products are already reserved for distribution by renowned pharmaceutical companies.

Complete dossiers available. All conditions negotiable.

VITROBIO is an ISO 13485 certified company, recipient of Best Research Institute award by the French Academy of Science.

Partnering consultation free of charge
EthyPharm
Therapeutic Area Partnerships
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us